LISA TRACKER – A tool of choice for the Monitoring of Biotherapies in ELISA
- Unique TDM menu with 12 different kits available for drug and anti-drug antibodies
- Full coverage of biotherapies used in IBD, but also other chronic inflammatory diseases and oncology
- Accurate quantitative measurement of drug and anti-drug antibodies
- Easy-to-use with standardized protocols from sample collection to result interpretation
- Clinically validated with measurement ranges tailored to induction and maintenance treatment phases
- Easy-to-implement ELISA kits validated on automated platforms (DS2, DSX, Evolis, etc.)
- Validated on biosimilars
- Validated and supported by the pharmaceutical industry
- Validated in accordance with the WHO international standards
- LISA TRACKER kits included in a high number of studies and publications
| Reference | Designation | Packaging |
|---|---|---|
| LTx 005 | LISA TRACKER Duo Drug + ADAb | 2 x 48 tests |
| LTx 002-48 | LISA TRACKER Drug | 48 tests |
| LTx 003-48 | LISA TRACKER Anti-Drug | 48 tests |
| LTT 004-96 | LISA TRACKER TNF | 96 tests |
| x = Infliximab/ Adalimumab/ Etanercept/ Certolizumab Pegol/ Golimumab/ Rituximab/ Secukinumab/ Tocilizumab/ Bevacizumab/ TRastuzumab/ Ustekinumab/Vedolizumab | ||
- A single monitoring menu with 12 different kits available for drug and anti-body / anti-drug dosage tests
- Full coverage of biotherapies used in IBD, but also in other diseases